FLAVIN-CONTAINING MONOOXYGENASE MEDIATED METABOLISM OF PSYCHOACTIVE-DRUGS BY HUMAN BRAIN MICROSOMES

被引:32
|
作者
BHAMRE, S
BHAGWAT, SV
SHANKAR, SK
BOYD, MR
RAVINDRANATH, V
机构
[1] NATL INST MENTAL HLTH & NEUROSCI,DEPT NEUROCHEM,BANGALORE 560029,KARNATAKA,INDIA
[2] NATL INST MENTAL HLTH & NEUROSCI,DEPT NEUROPATHOL,BANGALORE 560029,KARNATAKA,INDIA
[3] NCI,DEV THERAPEUT PROGRAM,DRUG DISCOVERY RES & DEV LAB,FREDERICK,MD 21702
关键词
BRAIN; FLAVIN-CONTAINING MONOOXYGENASE; METABOLISM; NEUROLEPTIC; ANTIDEPRESSANT; MONOOXYGENASE; HUMAN BRAIN;
D O I
10.1016/0006-8993(94)01135-5
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Flavin-containing monooxygenases (FMO) catalyze the oxidation of certain xenobiotics and drugs which contain a nucleophilic heteroatom. Here we report the first assessment of human brain flavin-containing monooxygenase from tissues obtained at autopsy from seven traffic accident victims. Human brain microsomes catalyzed the S-oxidation or N-oxidation of model substrates methimazole and N,N-dimethylaniline, respectively. The psychoactive drugs chlorpromazine, imipramine and fluoxetine, were also metabolized by human brain FMO. 'Western' immunoblot analyses revealed immunological cross-reactivity of the human brain FMO with rabbit pulmonary FMO. Immunocytochemistry further revealed the localization of the FMO predominantly in the neuronal cell bodies in the magnocellular reticular nuclei, colliculi and substantia nigra. Human brain clearly contains an active FMO system, and it is conceivable that such enzyme(s) are significantly involved in the local metabolism and modulation of pharmacological effects of psychoactive drugs.
引用
收藏
页码:276 / 280
页数:5
相关论文
共 50 条
  • [21] pH dependence on functional activity of human and mouse flavin-containing monooxygenase 5
    Motika, Meike S.
    Zhang, Jun
    Ralph, Erik C.
    Dwyer, Mary A.
    Cashman, John R.
    BIOCHEMICAL PHARMACOLOGY, 2012, 83 (07) : 962 - 968
  • [22] Relative contribution of cytochromes P-450 and flavin-containing monoxygenases to the metabolism of albendazole by human liver microsomes
    Rawden, HC
    Kokwaro, GO
    Ward, SA
    Edwards, G
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 49 (04) : 313 - 322
  • [23] Xenobiotic biotransforming enzymes in the central nervous system: An isoform of flavin-containing monooxygenase (FMO4) is expressed in rabbit brain
    Blake, BL
    Philpot, RM
    Levi, PE
    Hodgson, E
    CHEMICO-BIOLOGICAL INTERACTIONS, 1996, 99 (1-3) : 253 - 261
  • [24] Metabolism and Pharmacokinetics of the Anti-Tuberculosis Drug Ethionamide in a Flavin-Containing Monooxygenase Null Mouse
    Palmer, Amy L.
    Leykam, Virginia L.
    Larkin, Andrew
    Krueger, Sharon K.
    Phillips, Ian R.
    Shephard, Elizabeth A.
    Williams, David E.
    PHARMACEUTICALS, 2012, 5 (11): : 1147 - 1159
  • [25] FLAVIN-CONTAINING MONOOXYGENASE ACTIVITY IN LIVER-MICROSOMES FROM THE RAINBOW-TROUT (ONCORHYNCHUS-MYKISS)
    SCHLENK, D
    BUHLER, DR
    AQUATIC TOXICOLOGY, 1991, 20 (1-2) : 13 - 23
  • [26] MEASUREMENT OF PSYCHOACTIVE-DRUGS IN THE HUMAN BRAIN IN-VIVO BY MR SPECTROSCOPY
    KOMOROSKI, RA
    AMERICAN JOURNAL OF NEURORADIOLOGY, 1993, 14 (05) : 1038 - 1042
  • [27] Flavin-containing monooxygenase 3 gene polymorphisms in Turkish population
    Ozhan, Gul
    Topal, Pinar
    Alpertunga, Buket
    TOXICOLOGY MECHANISMS AND METHODS, 2012, 22 (06) : 461 - 465
  • [28] Mammalian flavin-containing monooxygenase (FMO) as a source of hydrogen peroxide
    Siddens, Lisbeth K.
    Krueger, Sharon K.
    Henderson, Marilyn C.
    Williams, David E.
    BIOCHEMICAL PHARMACOLOGY, 2014, 89 (01) : 141 - 147
  • [29] Human flavin-containing monooxygenase 3: Structural mapping of gene polymorphisms and insights into molecular basis of drug binding
    Gao, Chongliang
    Catucci, Gianluca
    Di Nardo, Giovanna
    Gilardi, Gianfranco
    Sadeghi, Sheila J.
    GENE, 2016, 593 (01) : 91 - 99
  • [30] Contribution of flavin-containing monooxygenase and cytochrome P450 to imipramine N-oxidation in rat hepatic microsomes
    Narimatsu, S
    Yamamoto, S
    Kato, R
    Masubuchi, Y
    Horie, T
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 1999, 22 (06) : 567 - 571